GM‐CSF is one of the main tumor‐derived soluble factors that can induce the differentiation of monocytic/granulocytic bone marrow cells into CD11b−Gr1− bone marrow progenitor cells, subsequently inducing them to differentiate into MDSCs [53]. The gene discussed is CSF2; the disease is neoplasm.